A randomized clinical trial conducted in seven countries has identified three new options for shorter, all-oral treatment of drug-resistant tuberculosis (TB), researchers reported this week in the New ...

HealthDay News — In a clinical practice guideline issued by the American Thoracic Society and published in the January issue of the American Journal of Respiratory and Critical Care Medicine, updated ...

The FDA granted marketing clearances for infectious disease tests, updates to a digital pathology system, and immunoassays for chronic diseases.

Treatment of isoniazid- and rifampin-susceptible TB in adults: A 4-month regimen of isoniazid, rifapentine, moxifloxacin, and ...

Use of novel regimens containing bedaquiline, pretomanid, and linezolid with or without moxifloxacin are included as recommendations for drug-resistant TB. For adolescents aged 14 years and older ...